Shravani Pasupneti, MD
Pulmonary Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pasupneti’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A130386 · Current
Licensed to practise in California · since 2014 · expires 2027-10-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125059375Temporary Medical Permit · since 2011 · expires 2014-06-23Specialty on the licence: Internal MedicineExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$101,918
Medicare paid this office $101,918 for 184 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 17 | $23,310 | $186 |
| Long return visit (40+ min) | 103 | $21,716 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $17,884 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $11,328 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $5,377 | $117 |
See all 10 services
| Critical care, first 30-74 minutes | 17 | $23,310 | $186 |
| Long return visit (40+ min) | 103 | $21,716 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $17,884 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $11,328 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $5,377 | $117 |
| Long return visit (40+ min) | 21 | $4,138 | $166 |
| Hospital discharge day management, 30 minutes or less | 28 | $2,384 | $74 |
| Return visit (30+ min) | 19 | $2,025 | $88 |
| New patient visit (60+ min) | 11 | $1,798 | $163 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $1,784 | $56 |
Who their Medicare patients are
184 Original Medicare patients in 2024. Average age 67 · Under 65 30% · Women 43% · Also on Medicaid 40% · Health risk score 3.70. Sicker patients than 9 in 10 peers; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Chronic kidney disease 65% · Diabetes 60% · COPD 51% · Coronary heart disease 47% · Heart failure 41% · Atrial fibrillation 36% · Depression 33% · Cancer 15% · Dementia 13% · Stroke 9%.
The office billed $555,816, Medicare allowed $127,818 and paid $101,918; for 885 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 184 | 885 | 67 | 3.70 | $555,816 | $101,918 |
| 2023 | 161 | 882 | 66 | 3.38 | $535,830 | $101,060 |
| 2022 | 162 | 1,005 | 67 | 3.40 | $567,163 | $107,512 |
| 2021 | 142 | 797 | 65 | 3.26 | $484,774 | $90,423 |
| 2020 | 84 | 357 | 64 | 3.77 | $173,774 | $33,819 |
| 2019 | 99 | 534 | 62 | 3.61 | $261,082 | $44,018 |
| 2018 | 51 | 243 | 61 | 3.73 | $151,804 | $23,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $20,514 | $110 |
| Critical care, first 30-74 minutes | 14 | $19,235 | $192 |
| Long return visit (40+ min) | 71 | $12,691 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $9,751 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $8,968 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $8,156 | $160 |
| Return visit (30+ min) | 60 | $6,923 | $90 |
| New patient visit (60+ min) | 17 | $2,505 | $147 |
| Aspiration of initial secretion of lung airway using an endoscope | 11 | $2,250 | $132 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $2,094 | $54 |
| Return visit (30+ min) | 12 | $1,450 | $97 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,442 | $72 |
2022: 11 services
| Critical care, first 30-74 minutes | 17 | $19,804 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $19,536 | $94 |
| Long return visit (40+ min) | 91 | $17,949 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $14,605 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $13,368 | $65 |
| Aspiration of initial secretion of lung airway using an endoscope | 24 | $3,687 | $119 |
| Return visit (30+ min) | 31 | $3,671 | $90 |
| New patient visit (60+ min) | 22 | $3,492 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $3,272 | $182 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,203 | $67 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 27 | $827 | $22 |
2021: 10 services
| Long return visit (40+ min) | 107 | $24,226 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $14,075 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $10,524 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $5,387 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $4,964 | $95 |
| Aspiration of initial secretion of lung airway using an endoscope | 14 | $2,373 | $113 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 26 | $2,304 | $58 |
| New patient visit (60+ min) | 11 | $2,063 | $188 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 12 | $1,962 | $164 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,494 | $68 |
2020: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $8,838 | $65 |
| Long return visit (40+ min) | 55 | $7,010 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $3,534 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $3,496 | $125 |
| Hospital discharge day management, 30 minutes or less | 14 | $1,082 | $64 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $19,970 | $65 |
| Long return visit (40+ min) | 48 | $5,371 | $99 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 27 | $2,345 | $73 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 14 | $2,335 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,829 | $122 |
| Hospital discharge day management, 30 minutes or less | 11 | $799 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $197 | $11 |
2018: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $6,276 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $3,370 | $94 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $1,870 | $94 |
| Long return visit (40+ min) | 13 | $1,397 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,266 | $115 |
Medicaid work
$1,534 in 2024
Medicaid paid $1,534 for 80 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 31 | $1,117 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 49 | $418 |
| 2024 | 80 | 2 | 15 | $1,534 |
| 2023 | 159 | 3 | 22 | $6,782 |
| 2022 | 68 | 1 | 20 | $2,793 |
| 2021 | 105 | 1 | 22 | $4,743 |
| 2020 | 12 | 1 | 12 | $621 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 95 | $4,429 |
| Long return visit (40+ min) | 35 | $1,730 |
| Return visit (30+ min) | 29 | $623 |
2022
| Long return visit (40+ min) | 68 | $2,793 |
2021
| Long return visit (40+ min) | 105 | $4,743 |
2020
| Long return visit (40+ min) | 12 | $621 |
Drugs they prescribed that Part D paid
$277,349
Pharmacies billed $277,349 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,185) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
1,079 generic and fewer than 11 brand-name prescriptions · $277,349 in drug cost · 157 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Posaconazole | 57 | $58,008 | $1,018 |
| Eliquis | 12 | $11,558 | $963 |
| Atovaquone | 14 | $10,720 | $766 |
| Valganciclovir | 41 | $3,431 | $84 |
| Tacrolimus | 37 | $2,622 | $71 |
See all 28 drugs
| Posaconazole | 57 | $58,008 | $1,018 |
| Eliquis | 12 | $11,558 | $963 |
| Atovaquone | 14 | $10,720 | $766 |
| Valganciclovir | 41 | $3,431 | $84 |
| Tacrolimus | 37 | $2,622 | $71 |
| Sirolimus | 12 | $1,787 | $149 |
| Mycophenolate Mofetil | 24 | $1,542 | $64 |
| Pantoprazole | 124 | $1,170 | $9 |
| Acyclovir | 75 | $836 | $11 |
| Nystatin | 27 | $806 | $30 |
| Rosuvastatin | 68 | $563 | $8 |
| Sulfamethoxazole-Trimethoprim | 85 | $471 | $6 |
| Azithromycin | 42 | $404 | $10 |
| Albuterol Sulfate Hfa | 12 | $322 | $27 |
| Prednisone | 63 | $303 | $5 |
| Gabapentin | 19 | $252 | $13 |
| Clotrimazole | 12 | $250 | $21 |
| Ondansetron Odt | 22 | $224 | $10 |
| Furosemide | 38 | $194 | $5 |
| Metoprolol | 26 | $142 | $5 |
| Metoprolol | 15 | $141 | $9 |
| Amlodipine Besylate | 37 | $128 | $3 |
| Atorvastatin | 22 | $111 | $5 |
| Levothyroxine | 20 | $81 | $4 |
| Tamsulosin | 14 | $63 | $4 |
| Famotidine | 14 | $55 | $4 |
| Amoxicillin | 11 | $28 | $3 |
| Sertraline | 13 | $16 | $1 |
Year by year
| 2024 | 1,185 | 154 | 0% (0) | None | $277,349 |
| 2023 | 852 | 136 | 0% (0) | None | $211,822 |
| 2022 | 791 | 130 | 0% (0) | 11% | $283,892 |
| 2021 | 635 | 117 | 0% (0) | None | $197,541 |
| 2020 | 151 | 42 | 0% (0) | 11% | $22,851 |
| 2019 | 198 | 36 | None | 15% | $76,231 |
| 2018 | 95 | 19 | 0% (0) | 23% | $75,960 |
| 2015 | 22 | None | 0% (0) | None | $2,109 |
| 2014 | 297 | 39 | None | None | $28,457 |
| 2013 | 358 | 45 | None | None | $35,098 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Posaconazole | 32 | $63,052 | $1,970 |
| Trelegy Ellipta | 29 | $22,899 | $790 |
| Eliquis | 11 | $14,432 | $1,312 |
| Itraconazole | 18 | $7,976 | $443 |
| Symbicort | 15 | $5,725 | $382 |
| Valganciclovir | 29 | $4,012 | $138 |
| Tacrolimus | 34 | $3,020 | $89 |
| Sirolimus | 12 | $2,443 | $204 |
| Mycophenolate Mofetil | 11 | $1,565 | $142 |
| Azithromycin | 44 | $1,257 | $29 |
| Acyclovir | 35 | $1,236 | $35 |
| Pantoprazole | 60 | $1,054 | $18 |
| Albuterol Sulfate Hfa | 20 | $837 | $42 |
| Rosuvastatin | 38 | $652 | $17 |
| Sulfamethoxazole-Trimethoprim | 59 | $440 | $7 |
| Prednisone | 38 | $341 | $9 |
| Amlodipine Besylate | 31 | $341 | $11 |
| Warfarin | 14 | $231 | $16 |
| Metoprolol | 19 | $229 | $12 |
| Levothyroxine | 16 | $124 | $8 |
| Gabapentin | 21 | $81 | $4 |
| Atorvastatin | 13 | $78 | $6 |
| Tamsulosin | 13 | $53 | $4 |
| Furosemide | 12 | $45 | $4 |
2022: 24 drugs
| Posaconazole | 18 | $53,677 | $2,982 |
| Itraconazole | 52 | $28,908 | $556 |
| Valganciclovir | 41 | $17,959 | $438 |
| Atovaquone | 15 | $10,163 | $678 |
| Symbicort | 18 | $6,446 | $358 |
| Tacrolimus | 40 | $6,066 | $152 |
| Sirolimus | 12 | $2,443 | $204 |
| Azithromycin | 35 | $1,858 | $53 |
| Nystatin | 23 | $1,630 | $71 |
| Cyclosporine Modified | 13 | $1,486 | $114 |
| Pantoprazole | 59 | $1,228 | $21 |
| Sulfamethoxazole-Trimethoprim | 62 | $822 | $13 |
| Rosuvastatin | 22 | $775 | $35 |
| Warfarin | 13 | $730 | $56 |
| Acyclovir | 25 | $706 | $28 |
| Diltiazem 24hr Er (Cd) | 15 | $551 | $37 |
| Prednisone | 52 | $477 | $9 |
| Pravastatin | 19 | $360 | $19 |
| Losartan | 18 | $311 | $17 |
| Escitalopram | 11 | $180 | $16 |
| Amlodipine Besylate | 28 | $140 | $5 |
| Metoprolol | 17 | $116 | $7 |
| Atorvastatin | 14 | $93 | $7 |
| Furosemide | 11 | $47 | $4 |
2021: 17 drugs
| Itraconazole | 42 | $30,845 | $734 |
| Atovaquone | 21 | $13,666 | $651 |
| Valganciclovir | 44 | $11,209 | $255 |
| Tacrolimus | 20 | $5,119 | $256 |
| Clotrimazole | 41 | $3,922 | $96 |
| Enoxaparin | 12 | $2,930 | $244 |
| Rosuvastatin | 24 | $923 | $38 |
| Azithromycin | 25 | $664 | $27 |
| Sulfamethoxazole-Trimethoprim | 66 | $583 | $9 |
| Pantoprazole | 26 | $508 | $20 |
| Acyclovir | 29 | $481 | $17 |
| Warfarin | 21 | $349 | $17 |
| Mirtazapine | 13 | $240 | $18 |
| Prednisone | 21 | $211 | $10 |
| Metoprolol | 18 | $73 | $4 |
| Amlodipine Besylate | 19 | $72 | $4 |
| Atorvastatin | 11 | $63 | $6 |
2020: 3 drugs
| Azithromycin | 14 | $244 | $17 |
| Acyclovir | 13 | $151 | $12 |
| Sulfamethoxazole-Trimethoprim | 12 | $77 | $6 |
2019: 3 drugs
| Pantoprazole | 30 | $398 | $13 |
| Prednisone | 14 | $87 | $6 |
| Sulfamethoxazole-Trimethoprim | 18 | $56 | $3 |
2014: 6 drugs
| Nexium | 13 | $4,789 | $368 |
| Atorvastatin | 30 | $1,261 | $42 |
| Lisinopril | 24 | $241 | $10 |
| Triamterene-Hydrochlorothiazid | 17 | $201 | $12 |
| Simvastatin | 12 | $198 | $16 |
| Amlodipine Besylate | 11 | $46 | $4 |
2013: 9 drugs
| Spiriva | 12 | $3,366 | $281 |
| Atorvastatin | 21 | $1,270 | $60 |
| Nifedipine Er | 13 | $873 | $67 |
| Lisinopril | 30 | $270 | $9 |
| Triamterene-Hctz | 11 | $209 | $19 |
| Tamsulosin | 13 | $204 | $16 |
| Amlodipine Besylate | 14 | $131 | $9 |
| Simvastatin | 15 | $124 | $8 |
| Spironolactone | 13 | $98 | $8 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1972899615
- Licence
- CA A130386, IL 125.059375California A130386: Current · expires 2027-10-31Illinois 125059375: Expired
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 300 Pasteur Dr Rm H3143, Mc: 5236, Stanford, CA, 94305
- NPI first listed
- 2011-06-21
- NPI last updated
- 2021-11-24
- NPI record certified
- 2021-11-24
This is when the NPI record was last certified, not a medical board exam.